Faculty

Institution

Unit

Venue

Qiongyu Hao

Charles R. Drew University of Medicine and Science

Affiliations

Center For Health Services Research

Center Of Clinical Research

Institute Of Medical Sciences

NoneQiongyu Hao is currently serving as a Center For Health Services Research faculty at Charles R. Drew University of Medicine And Science.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Qiongyu Hao

Charles R. Drew University of Medicine and Science

You can click a keyword to filter the displayed items

pharmacology cancer research cell biology tumor biology cancer cells oncogenes breast cancer oncology molecular cancer cancer discovery anti-cancer agents immunology cancer biology breast oncology therapeutic targets medicinal research enzyme inhibition chemoprevention strategies pathology cell signaling tumor targeting carcinogenesis cancer immunotherapy diabetes therapies cancer treatment cancer genetics non-coding rna cellular therapy vascular biology molecular diagnostics liver physiology diabetes research long non-coding rna drug targeting diabetes mellitus prostatic disease metabolic remodeling triple-negative breast cancer pharmacological research cardiovascular research phytotherapy research natural product research signaling pathways cancer immunosurveillance extracellular microvesicles insulin signaling skeletal muscle metabolic regulation tumor suppressors oncogenic agent myocardial infarction microvascular dysfunction pulmonary arterial hypertension blood pressure antihypertensive therapy phytochemicals phytopharmacology medical nutrition functional selectivity appetite control metabolic control cancer pathogenesis amp-activated protein kinase potential therapeutic target breast cancer prevention tumor-derived exosomes insulin resistance epigenetic repression molecular mechanisms studies tumor growth adipose tissue dual actions diabetes‐associated breast cancer dna damage response immunotherapy response mir-192 family/xiap axis

Notable Scholarly Works

Notable Federal Grants

Collaborators

CORRECTION: Hao Et Al. Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin With Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules 2024, 14, 105. Biomolecules (2025)

pharmacologyurologychemoprevention strategiesdrug discoverycancer researchcancer lettercancer discoverygreen teaanti-cancer agentspharmacognosyprostatic diseaseprostate-specific phosphataseprostate cancer

Abstract C109: Identifying a Novel Metabolic Reprogramming Strategy to Inhibit Diabetes-Associated Tnbc in African American. Cancer Epidemiology Biomarkers & Prevention (2024)

pharmacologyhealth sciencesdiabetes therapieschronic diseasesdiabetes-associated tnbcmetabolic syndromediabetes researchnovel metabolicdiabetesabstract c109metabolic remodelingmetabolic pathwaysdiabetes mellitus

Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin With Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules (2024)

Qiongyu HaoSusanne M. HenningClara E. MagyarJonathan SaidJin ZhongMatthew B. RettigJaydutt V. VadgamaPiwen Wang

neurologypharmacologyurologycancer treatmentdrug discoverychemoprevention strategiestumor targetingcancer researchmolecular medicineoncologyenhanced chemopreventionenzyme inhibitiondrug targetinganti-cancer agentsmedicinal researchprostate-specific phosphataseprotein scienceprostate cancer

Ftx Promotes Esophageal Cancer Progression and Desensitizes Esophageal Cancer Cells to Ionizing Radiation by Microrna-99A/B-3P/Wee1/Ercc1 Axis. ONCOLOGIE (2024)

Yangjie XuChaoming HuangZijuan MaoYuanyuan FuQiongyu HaoZhenghua Fei

cancer progressiononcologyesophageal cancerradiation oncology

A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer. Advanced Science (2022)

pharmacologymetabolismmetabolic controlbreast cancerbreast oncologydiabetes therapiesdiabetes carecell metabolismmolecular metabolismsystems biologydiabetespersonalized medicinediabetes‐associated breast cancermetabolic remodelingmetabolic pathwaysmetabolic engineering

Circkif5B Promotes Hepatocellular Carcinoma Progression by Regulating the Mir-192 Family/Xiap Axis. Frontiers in Oncology (2022)

small rnapathologymolecular cancermolecular cell biologycancer cellsnon-coding rnaoncogenesmir-192 family/xiap axiscancer researchliver physiologyhepatocellular carcinomatumor biologycarcinogenesiscell biology

Circrad54L2 Promotes Triple-Negative Breast Cancer Progression by Regulating the Mir-888 Family/Pdk1 Axis. Life Sciences (2022)

cancer biologymolecular cancerbreast cancerbreast oncologyoncogenesmicrorna detectionnon-coding rnacancer discoverymir-888 family/pdk1 axistumor biologyimmunologycell biology

Zbed2 Expression Enhances Interferon Signaling and Predicts Better Survival of Estrogen Receptor‐Negative Breast Cancer Patients. Cancer Communications (2022)

cancer biologygene expressionbreast cancercancer cellsoncogenescancer researchbreast oncologytranscription factorscancer lettercancer discoverycell signalingimmunologycarcinogenesiscell biologyendocrine-related cancers

Oncogenic Signaling Pathway-Related Long Non-Coding Rnas for Predicting Prognosis and Immunotherapy Response in Breast Cancer. Frontiers in Immunology (2022)

cancer immunotherapybreast cancerbreast oncologyoncogenesnon-coding rnaimmunotherapy responselong non-coding rnacancer genomicsimmunologycell biologymolecular diagnostics

Phytochemicals in Inhibition of Prostate Cancer: Evidence From Molecular Mechanisms Studies. Biomolecules (2022)

phytochemical analysisanti-cancer agentsphytopharmacologyprostatic diseasemedicinal foodspharmacologychemoprevention strategiesphytotherapy researchnatural product researchbioactive compoundsmolecular mechanisms studiesprostate cancerurologynatural productsdrug discoveryenzyme inhibitionphytochemicalsmolecular pharmacologytherapeutic targets

1
2
3
10 / page

Qiongyu Hao

Charles R. Drew University of Medicine and Science

Affiliations

Center For Health Services Research

Center Of Clinical Research

Institute Of Medical Sciences

NoneQiongyu Hao is currently serving as a Center For Health Services Research faculty at Charles R. Drew University of Medicine And Science.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Qiongyu Hao

Charles R. Drew University of Medicine and Science

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract C109: Identifying a Novel Metabolic Reprogramming Strategy to Inhibit Diabetes-Associated Tnbc in African American. Cancer Epidemiology Biomarkers & Prevention (2024)

Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin With Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules (2024)

Qiongyu HaoSusanne M. HenningClara E. MagyarJonathan SaidJin ZhongMatthew B. RettigJaydutt V. VadgamaPiwen Wang

Ftx Promotes Esophageal Cancer Progression and Desensitizes Esophageal Cancer Cells to Ionizing Radiation by Microrna-99A/B-3P/Wee1/Ercc1 Axis. ONCOLOGIE (2024)

Yangjie XuChaoming HuangZijuan MaoYuanyuan FuQiongyu HaoZhenghua Fei

cancer progressiononcologyesophageal cancerradiation oncology

A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer. Advanced Science (2022)

Circkif5B Promotes Hepatocellular Carcinoma Progression by Regulating the Mir-192 Family/Xiap Axis. Frontiers in Oncology (2022)

Circrad54L2 Promotes Triple-Negative Breast Cancer Progression by Regulating the Mir-888 Family/Pdk1 Axis. Life Sciences (2022)

cancer biologymolecular cancerbreast cancerbreast oncologyoncogenesmicrorna detectionnon-coding rnacancer discoverymir-888 family/pdk1 axistumor biologyimmunologycell biology

Zbed2 Expression Enhances Interferon Signaling and Predicts Better Survival of Estrogen Receptor‐Negative Breast Cancer Patients. Cancer Communications (2022)

Oncogenic Signaling Pathway-Related Long Non-Coding Rnas for Predicting Prognosis and Immunotherapy Response in Breast Cancer. Frontiers in Immunology (2022)

cancer immunotherapybreast cancerbreast oncologyoncogenesnon-coding rnaimmunotherapy responselong non-coding rnacancer genomicsimmunologycell biologymolecular diagnostics

Phytochemicals in Inhibition of Prostate Cancer: Evidence From Molecular Mechanisms Studies. Biomolecules (2022)

1
2
3
10 / page